Alexis Bosman

Derivation of human embryonic stem cell lines.

Karyotypically normal and abnormal human embryonic stem cell lines derived from PGD-analyzed embryos.

Derivation of the first Swiss human embryonic stem cell line from a single blastomere of an arrested four-cell stage embryo.

The generation of six clinical-grade human embryonic stem cell lines.

Derivation of three new human embryonic stem cell lines.

A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes.

Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.

Molecular and functional evidence of HCN4 and caveolin-3 interaction during cardiomyocyte differentiation from human embryonic stem cells.

Human stem cell-based three-dimensional microtissues for advanced cardiac cell therapies.

Perturbations of heart development and function in cardiomyocytes from human embryonic stem cells with trisomy 21.

Bioengineering and Stem Cell Technology in the Treatment of Congenital Heart Disease.

A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.

Damage-inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter.

Human Hepatocyte-Derived Induced Pluripotent Stem Cells: MYC Expression, Similarities to Human Germ Cell Tumors, and Safety Issues.

Derivation of Genea002 human embryonic stem cell line.

Derivation of Trisomy 21 affected human embryonic stem cell line Genea021.

Derivation of human embryonic stem cell line Genea023.

Derivation of human embryonic stem cell line Genea022.